Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women

Clinical Science

Volumn 113, Issue 9-10, 2007, Pages 383-391

  Peverill, Roger E ^a   Teede, Helena J ^b   Malan, Erica ^a   Kotsopoulos, Dimitra ^b   Smolich, Joseph J ^a   McGrath, Barry P ^b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Adiposity; Body mass index (BMI); Coagulation; Fibrinolysis; Hip circumference; Obesity; Waist to hip ratio (WHR)

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; D DIMER; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; BLOOD CHEMISTRY; BLOOD CLOTTING; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRIN FORMATION; FIBRIN METABOLISM; FIBRINOLYSIS; HIP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THROMBOSIS; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FACTOR VII; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; LINEAR MODELS; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTMENOPAUSE; PROTEIN PRECURSORS; PROTHROMBIN; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 36348983866     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070084     Document Type: Article

References (47)

1. National Heart, Lung Blood Institute (1998) Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report, National Institutes of Health, Bethesda, MD, U.S.A.
2. Lissner, L., Bjorkelund, C., Heitmann, B. L., Seidell, J. C. and Bengtsson, C. (2001) Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes. Res. 9, 644-646
3. Yusuf, S., Hawken, S., Ounpuu, S. et al. (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640-1649
4. Bigaard, J., Frederiksen, K., Tjonneland, A. et al. (2004) Waist and hip circumferences and all-cause mortality: usefulness of the waist-to-hip ratio? Int. J. Obes. Relat. Metab. Disord. 28, 741-747
5. Rexrode, K. M., Carey, V. J., Hennekens, C. H. et al. (1998) Abdominal adiposity and coronary heart disease in women. JAMA, J. Am. Med. Assoc. 280, 1843-1848
6. Kurth, T., Gaziano, J. M., Berger, K. et al. (2002) Body mass index and the risk of stroke in men. Arch. Intern. Med. 162, 2557-2562
7. Wolk, R., Berger, P., Lennon, R. J., Brilakis, E. S. and Somers, V. K. (2003) Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 108, 2206-2211
8. Goldhaber, S. Z., Grodstein, F., Stampfer, M. J. et al. (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA, J. Am. Med. Assoc. 277, 642-645
9. Hansson, P. O., Eriksson, H., Welin, L., Svardsudd, K. and Wilhelmsen, L. (1999) Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: 'the study of men born in 1913'. Arch. Intern. Med. 159, 1886-1890
10. Skurk, T. and Hauner, H. (2004) Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int. J. Obes. Relat. Metab. Disord. 28, 1357-1364
11. Rugman, F. P., Jenkins, J. A., Duguid, J. K., Maggs, P. B. and Hay, C. R. (1994) Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors. Blood Coagulation Fibrinolysis 5, 335-340
12. Bowles, L. K., Cooper, J. A., Howarth, D. J., Miller, G. J. and MacCallum, P. K. (2003) Associations of haemostatic variables with body mass index: a community-based study. Blood Coagulation Fibrinolysis 14, 569-573
13. Yarnell, J. W., Sweetnam, P. M., Rumley, A. and Lowe, G. D. (2001) Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagulation Fibrinolysis 12, 721-728
14. Woodward, M., Lowe, G. D., Rumley, A. et al. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br. J. Haematol. 97, 785-797
15. Cushman, M., Psaty, B. M., Macy, E. et al. (1996) Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 16, 1163-1169
16. Cushman, M., Folsom, A. R., Wang, L. et al. (2003) Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 101, 1243-1248
17. Koenig, W., Rothenbacher, D., Hoffmeister, A., Griessnammer, M. and Brenner, H. (2001) Plasma fibrin D-dimer levels and risk of stable coronary artery disease: Results of a large case-control study. Arterioscler. Thromb. Vasc. Biol. 21, 1701-1705
18. Cortellaro, M., Cofrancesco, E., Boschetti, C. et al. (1993) Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. Arterioscl. Thromb. 13, 1412-1417
19. Lowe, G. D., Sweetnam, P. M., Yarnell, J. W. et al. (2004) C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies. Arterioscler. Thromb. Vasc. Biol. 24, 1957-1962
20. Ridker, P. M., Hennekens, C. H., Cerskus, A. and Stampfer, M. J. (1994) Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 90, 2236-2240
21. Lowe, G. D., Rumley, A., McMahon, A. D., Ford, I., O'Reilly, D. S. and Packard, C. J. (2004) Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 24, 1529-1534
22. Cushman, M., Lemaitre, R. N., Kuller, L. H. et al. (1999) Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 19, 493-498
23. Teede, H. J., McGrath, B. P., Smolich, J. J. et al. (2000) Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler. Thromb. Vasc. Biol. 20, 1404-1409
24. Teede, H. J., Dalais, F. S., Kotsopoulos, D., Liang, Y. L., Davis, S. and McGrath, B. P. (2001) Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J. Clin. Endocrinol. Metab. 86, 3053-3060
25. WHO (1995) Physical Status: the Use and Interpretation of Anthropometry, World Health Organization, Geneva
26. MacCallum, P. K., Cooper, J. A., Martin, J., Howarth, D. J., Meade, T. W. and Miller, G. J. (2000) Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma. Thromb. Haemostasis 83, 421-426
27. Lowe, G. D., Rumley, A., Woodward, M. et al. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br. J. Haematol. 97, 775-784
28. Hursting, M. J., Stead, A. G., Crout, F. V., Horvath, B. Z. and Moore, B. M. (1993) Effects of age, race, sex, and smoking on prothrombin fragment 1. 2 in a healthy population. Clin. Chem. 39, 683-686
29. Harris, G. M., Stendt, C. L., Vollenhoven, B. J., Gan, T. E. and Tipping, P. G. (1999) Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Am. J. Hematol. 60, 175-180
30. Kapiotis, S., Jilma, B., Quehenberger, P., Ruzicka, K., Handler, S. and Speiser, W. (1997) Morning hypercoagulability and hypofibrinolysis: diurnal variations in circulating activated factor VII, prothrombin fragment F1 + 2, and plasmin-plasmin inhibitor complex. Circulation 96, 19-21
31. Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C. and Heath, Jr, C. W., (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 341, 1097-1105
32. Romano, M., Guagnano, M. T., Pacini, G. et al. (2003) Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J. Clin. Endocrinol. Metab. 88, 5321-5326
33. Cadroy, Y., Pierrejean, D., Fontan, B., Sie, P. and Boneu, B. (1992) Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouv. Rev. Fr. Hematol. 34, 43-46
34. Smith, E. B. (1995) Fibrinogen, fibrin and the arterial wall. Eur. Heart J. 16 (Suppl. A), 11-14
35. Bauer, K. A., Weiss, L. M., Sparrow, D., Vokonas, P. S. and Rosenberg, R. D. (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J. Clin. Invest. 80, 1527-1534
36. Prentice, A. M. and Jebb, S. A. (2001) Beyond body mass index. Obes. Rev. 2, 141-147
37. Bauer, K. A. (1999) Activation markers of coagulation. Bailliere's Best Practice Clin. Haematol. 12, 387-406
38. Ferguson, M. A., Gutin, B., Owens, S., Litaker, M., Tracy, R. P. and Allison, J. (1998) Fat distribution and hemostatic measures in obese children. Am. J. Clin. Nutr. 67, 1136-1140
39. Alessi, M. C., Peiretti, F., Morange, P., Henry, M., Nalbone, G. and Juhan-Vague, I. (1997) Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46, 860-867
40. Eriksson, P., Reynisdottir, S., Lonnqvist, F., Stemme, V., Hamsten, A. and Arner, P. (1998) Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 41, 65-71
41. Juhan-Vague, I., Alessi, M. C., Mavri, A. and Morange, P. E. (2003) Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J. Thromb. Haemostasis 1, 1575-1579
42. Snijder, M. B., Dekker, J. M., Visser, M. et al. (2003) Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am. J. Clin. Nutr. 77, 1192-1197
43. Snijder, M. B., Zimmet, P. Z., Visser, M., Dekker, J. M., Seidell, J. C. and Shaw, J. E. (2004) Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int. J. Obes. Relat. Metab. Disord. 28, 402-409
44. Tanko, L. B., Bagger, Y. Z., Alexandersen, P., Larsen, P. J. and Christiansen, C. (2003) Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 107, 1626-1631
45. Van Pelt, R. E., Evans, E. M., Schechtman, K. B., Ehsani, A. A. and Kohrt, W. M. (2002) Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am. J. Physiol. Endocrinol. Metab. 282, E1023-E1028
46. Van Pelt, R. E., Jankowski, C. M., Gozansky, W. S., Schwartz, R. S. and Kohrt, W. M. (2005) Lower-body adiposity and metabolic protection in postmenopausal women. J. Clin. Endocrinol. Metab. 90, 4573-4578
47. Samad, F., Pandey, M. and Loskutoff, D. J. (2001) Regulation of tissue factor gene expression in obesity. Blood 98, 3353-3358